Skip to main content

Day: January 30, 2025

AppFolio, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results

Fourth quarter caps off year of innovation including new AppFolio Realm-X capabilities and a transformed resident vision SANTA BARBARA, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — AppFolio, Inc. (NASDAQ: APPF) (“AppFolio” or the “Company”), a technology leader powering the future of the real estate industry, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2024. “I am proud of our strong performance in 2024 as we continue to deliver value to our customers through differentiated industry-leading innovation,” said Shane Trigg, President and CEO, AppFolio. “Our investments in AI and the resident experience are translating into meaningful outcomes for our customers and fueling our mission to build the platform where the real estate industry comes...

Continue reading

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025

Year-over-year revenue grows 10%, operating profit up 52%, non-GAAP operating profit up 19% Operating cash flow of $309 millionNote: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Jan. 30, 2025 (GLOBE NEWSWIRE) — ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2024. Second Quarter 2025 HighlightsAll comparisons are to the prior year periodRevenue increased by 10% to $1.3 billion; up 10% on a constant currency basis  Gross margin improved 300 bps to 58.6%; non-GAAP gross margin improved 230 bps to 59.2% Income from operations increased 52%; non-GAAP income from operations up 19% Operating cash flow of $309 million Diluted earnings per share of $2.34; non-GAAP diluted earnings per share of $2.43“Our second quarter...

Continue reading

Cavco Industries Reports Fiscal 2025 Third Quarter Results

PHOENIX, Jan. 30, 2025 (GLOBE NEWSWIRE) — Cavco Industries, Inc. (Nasdaq: CVCO) (“we,” “our,” the “Company” or “Cavco”) today announced financial results for the third fiscal quarter ended December 28, 2024. Quarterly HighlightsNet revenue was $522 million, up $75 million or 16.8% compared to $447 million in the third quarter of the prior year, primarily on home sales volume growth. Home sales volume is up 21.6% and capacity utilization is up to approximately 75% from approximately 60% in the third quarter of the prior year. Factory-built housing Gross profit as a percentage of Net revenue was 23.6%, compared to 22.4% in the prior year period. Financial services Gross profit as a percentage of Net revenue was 55.5%, compared to Gross profit of 36.8% in the prior year period. Income...

Continue reading

CN Announces Fourth Quarter and Year-End Results

Railroad Expects to Deliver 10%-15% EPS Growth in 2025 MONTREAL, Jan. 30, 2025 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) today reported its financial and operating results for the fourth quarter and year ended December 31, 2024. “Thanks to our team and the strength of our operating model, we were able to quickly recover from several shocks across the supply chain in 2024. We have good momentum as 2025 begins, and we are well positioned to drive growth with our customers and operating leverage across our system.” – Tracy Robinson, President and Chief Executive Officer, CN Financial results highlights Fourth-quarter 2024 compared to fourth-quarter 2023Revenue ton miles (RTMs) of 59,305 (millions), a decrease of 3%. Revenues of C$4,358 million, a decrease of C$113 million, or 3%. Operating income of C$1,628 million, a decrease...

Continue reading

Orchid Island Capital Announces Fourth Quarter 2024 Results

VERO BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) — Orchid Island Capital, Inc. (NYSE:ORC) (“Orchid” or the “Company”), a real estate investment trust (“REIT”), today announced results of operations for the three and twelve month periods ended December 31, 2024. Fourth Quarter 2024 ResultsNet income of $5.6 million, or $0.07 per common share, which consists of:Net interest income of $8.1 million, or $0.10 per common share Total expenses of $4.4 million, or $0.05 per common share Net realized and unrealized gains of $1.8 million, or $0.02 per common share, on RMBS and derivative instruments, including net interest income on interest rate swapsFourth quarter total dividends declared and paid of $0.36 per common share Total return of 0.60%, comprised of $0.36 dividends per common share and a $0.31 decrease...

Continue reading

Medallion Bank Reports 2024 Fourth Quarter and Full-Year Results and Declares Series F Preferred Stock Dividend

SALT LAKE CITY, Jan. 30, 2025 (GLOBE NEWSWIRE) — Medallion Bank (Nasdaq: MBNKP, the “Bank”), an FDIC-insured bank specializing in consumer loans for the purchase of recreational vehicles, boats, and home improvements, as well as loan products and services offered through fintech strategic partners, today announced its results for the quarter and year ended December 31, 2024. The Bank is a wholly owned subsidiary of Medallion Financial Corp. (Nasdaq: MFIN). 2024 Fourth Quarter HighlightsNet income of $15.6 million, compared to $21.9 million in the prior year quarter. Net interest income of $53.1 million, compared to $48.9 million in the prior year quarter. Net interest margin of 8.28%, compared to 8.62% in the prior year quarter. Total provision for credit losses was $20.5 million, compared to $9.7 million in the prior year quarter....

Continue reading

Credit Acceptance Announces Fourth Quarter and Full Year 2024 Results

Southfield, Michigan, Jan. 30, 2025 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) today announced consolidated net income of $151.9 million, or $12.26 per diluted share, for the three months ended December 31, 2024 compared to consolidated net income of $93.6 million, or $7.29 per diluted share, for the same period in 2023. Adjusted net income, a non-GAAP financial measure, for the three months ended December 31, 2024 was $126.0 million, or $10.17 per diluted share, compared to $129.1 million, or $10.06 per diluted share, for the same period in 2023. The following table summarizes our financial results:(In millions, except per share data)   For the Three Months Ended   For the Years Ended    December 31, 2024   September 30, 2024   December...

Continue reading

Nokia Corporation: Repurchase of own shares on 30.01.2025

Nokia CorporationStock Exchange Release30 January 2025 at 22:30 EET Nokia Corporation: Repurchase of own shares on 30.01.2025 Espoo, Finland – On 30 January 2025 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 872,093 4.53CEUX – –BATE – –AQEU – –TQEX – –Total 872,093 4.53* Rounded to two decimals On 22 November 2024, Nokia announced that its Board of Directors is initiating a share buyback program to offset the dilutive effect of new Nokia shares issued to the shareholders of Infinera Corporation and certain Infinera Corporation share-based incentives. The repurchases in compliance with the Market Abuse Regulation (EU) 596/2014...

Continue reading

Axsome Therapeutics Announces FDA Approval of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

A single oral dose of SYMBRAVO provided rapid migraine pain freedom and return to normal functioning within 2 hours, and sustained efficacy through 24 and 48 hours 85% and 77% of patients treated with a single dose of SYMBRAVO did not require migraine rescue medication within 24 hours in two Phase 3 studies SYMBRAVO demonstrated superior efficacy across a broad range of migraine severity (mild, moderate, and severe), and in head-to-head evaluation SYMBRAVO incorporates Axsome’s rapid absorption technology and mechanisms that target multiple migraine attack pathways Company to host conference call and webcast Friday, January 31, at 8:00 AM Eastern NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders,...

Continue reading

Regional Health Properties, Inc. Announces Distribution of Common Stock to Holders of its 12.5% Series B Cumulative Redeemable Preferred Shares

Atlanta, GA, Jan. 30, 2025 (GLOBE NEWSWIRE) — Regional Health Properties, Inc. (“Regional”) (NYSE American: RHE) (NYSE American: RHE-PA) announced today that its Board of Directors declared a dividend to the holders of its 12.5% Series B Cumulative Redeemable Preferred Shares (the “Series B Preferred Stock”), on a pro rata basis in proportion to the number of shares of Series B Preferred Stock held by such holders, of 250,000 shares of the Company’s common stock (“Common Stock”), rounded down to the nearest whole share of Common Stock. The dividend will be paid on or about February 19, 2025 to holders of record of the Series B Preferred Stock as of the close of business on February 10, 2025. Regional is required to pay the dividend of Common Stock to such holders of Series B Preferred Stock pursuant to the terms of Regional’s Amended...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.